MicroRNA-657 promotes tumorigenesis in hepatocellular carcinoma by targeting transducin-like enhancer protein 1 through nuclear factor kappa B pathways

Lisheng Zhang, Lixin Yang, Xiyong Liu, Wei Chen, Lufen Chang, Linling Chen, Sofia Loera, Peiguo Chu, Wei Chien Huang, Yun Ru Liu, Yun Yen

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Growing evidence indicates that deregulation of microRNAs (miRNAs) contributes to tumorigenesis. Dysregulation of miR-657 has been observed in several types of cancers, but its biological function is still largely unknown. Our results showed that miR-657 expression can be induced by hepatitis viral proteins and is significantly increased in hepatocellular carcinoma (HCC) tissues. Moreover, introduction of miR-657 dramatically increases proliferation and colony formation of HCC cells in vitro and induces tumor development in immunodeficient mice. Further studies showed that miR-657 directly targets the transducin-like enhancer protein 1 (TLE1) 3′ untranslated region (UTR) and activates nuclear factor kappa B (NF-κB) pathways that contribute to hepatocarcinogenesis. Conclusion: This study identified a mechanism whereby miRNA-657 contributed to HCC through novel cancer pathways and provides new insights into the potential molecular mechanisms of hepatic carcinogenesis. (HEPATOLOGY 2013)

Original languageEnglish
Pages (from-to)1919-1930
Number of pages12
JournalHepatology
Volume57
Issue number5
DOIs
Publication statusPublished - May 1 2013

ASJC Scopus subject areas

  • Hepatology

Fingerprint Dive into the research topics of 'MicroRNA-657 promotes tumorigenesis in hepatocellular carcinoma by targeting transducin-like enhancer protein 1 through nuclear factor kappa B pathways'. Together they form a unique fingerprint.

  • Cite this